News and Events

News

Adam Duerfeldt seated with bookshelf behind him

Associate professor Adam Duerfeldt, PhD, joined the College of Pharmacy’s Department of Medicinal Chemistry on Dec. 28, 2020. 

Dr. Gunda Georg was quoted in the recent Nature article "Stopping Sperm at the Source" discussing her research into the development of a male contraceptive. From the article,

Three of our graduate students were selected to receive the 2020-2021 Bighley Graduate Fellowship: Erik Faber (Georg Lab), Jian Tang (Harki Lab), and Nan Wang (Georg Lab). The fellowship supports exceptional graduate students working in the biomedical health sciences with an emphasis on collaborative and interdisciplinary work.

Dr. Kathryn Nelson has been selected to receive the Wallin Neuroscience Discovery Award as co-PI for her project "Bringing Breakthroughs in Alzheimer’s Disease to American Indian Communities." The award will provide $99,970 in total funding for the year. 

A new 5-year R01 grant from the NIH/NICHD was awarded to Dr. Gunda Georg for the discovery of NaK-ATPase alpha4 inhibitors for non-hormonal male contraception. This is a collaborative project with Professor Gustavo Blanco at the University of Kansas Medical Center.

Pooja Hegde, a graduate student in the Aldrich lab, received an award for her entry in the University's 3-Minute Thesis Competition. Pooja was awarded the Associate Dean of Research and Graduate Education's Choice Award, which includes a $500 travel grant, for her thesis presentation "“Making PAS Great Again.”


A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1

Schwarz, D. M. C.;  Williams, S. K.;  Dillenburg, M.Wagner, C. R.; Gestwicki, J. E. ACS Med Chem Lett 2020, 11 (9), 1704-1710.

Drs. Erin Carlson (PI) and Elizabeth Ambrose (co-PI) were awarded a new R01 grant from the National Institutes of Health for the project "Chemical Methods to Characterize Penicilllin-Binding Protein Function and Interactions.” The grant will provide over $1 million in total funding through 2024. 

Dr. Vadim Gurvich was awarded a new $55K contract with the National Institute on Aging for Developing of (-)-Phenserine for Clinical Studies. 

Drs. Vadim Gurvich (PI), Gunda Georg (Co-PI), and Michael Walters (Co-PI) received a 2nd-year renewal of their contract with the National Center for Advancing Translational Sciences (NCATS). The contract will provide $845K in funding for medicinal chemistry support on the development of an antagonist for Substance Use Disorder (SUD).

Pages